首页 | 本学科首页   官方微博 | 高级检索  
检索        


Dilated cardiomyopathy and thrombo-embolism
Authors:J Günthard  F Stocker  D Bolz  E Jäggi  R Ghisla  I Oberhänsli  F Wyler
Institution:Postfach, R?mergasse 8, Tel.: 61 861 18 00 (P), Tel.: 61 691 26 26 (B), Fax: 61 692 65 55 (B), CH-4005 Basel, Switzerland, CH
University Children's Hospital, Barno, Switzerland, University Children's Hospital, Barno, CH
University Children's Hospital, Zürich, Switzerland, University Children's Hospital, Zürich, CH
University Children's Hospital, Geneva, Switzerland, University Children's Hospital, Geneva, CH
University Children's Hospital, St. Gallen, Switzerland, University Children's Hospital, St. Gallen, CH
Abstract:The purpose of this study was to investigate the incidence, outcome and prevention of thrombo-embolism in children with dilated cardiomyopathy. From 130 patients with dilated cardiomyopathy, 17 (14%) showed evidence of thrombo-embolism. Seven had initial cardiac thrombus, 7 exhibited initial embolus and in 3 thrombo-embolism was only diagnosed at autopsy. All 17 patients showed seriously impaired systolic function of the left ventricle with fractional shortening (FS) of 10?±?3%, range 5%–17%, as compared to those without thrombo-embolism with FS of 17%?±?6%, range 5%–26% (P?<;?0.0001). Seven patients were treated with oral anticoagulants once thrombo-embolism had been diagnosed; one of them experienced a further embolic event as opposed to three out of four patients not treated with anticoagulants. Conclusion?All children with dilated cardiomyopathy and fractional shortening below 20% should be treated with prophylactic anticoagulative agents
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号